Stryker ( (SYK) ) has provided an announcement.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Stryker Corporation has announced a definitive agreement to acquire Inari Medical, Inc. for $80 per share, with a total equity value of approximately $4.9 billion. This acquisition is set to enhance Stryker’s position in the peripheral vascular segment, expanding its portfolio with Inari’s innovative solutions for venous thromboembolism, complementing Stryker’s existing Neurovascular business. The transaction, expected to close by the first quarter of 2025, aims to improve patient outcomes and elevate the standard of care in endovascular procedures.
More about Stryker
Stryker is a global leader in medical technologies, offering innovative products and services in MedSurg, Neurotechnology, Orthopaedics, and Spine, impacting over 150 million patients annually. Inari Medical, founded in 2011, specializes in peripheral vascular diseases, providing solutions for venous thromboembolism without thrombolytic drugs.
YTD Price Performance: 0.78%
Average Trading Volume: 1,212,241
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $137.8B
Find detailed analytics on SYK stock on TipRanks’ Stock Analysis page.
